XML 81 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Loss Per Share Attributable to Common Stockholders - Graphite Bio, Inc. (Tables)
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Summary of Computation of Basic and Diluted Net Loss Per Share
The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders, which excludes shares which are legally outstanding, but subject to repurchase by the Company (in thousands, except share and per share amounts):
Year Ended December 31,
20232022
Numerator:
Net loss$(124,651)$(101,052)
Denominator:
Weighted-average common shares outstanding58,046,553 58,111,437 
Less: weighted-average unvested restricted shares and shares subject to repurchase(1,031,394)(3,237,762)
Weighted-average shares used to compute basic and diluted net loss per share attributable to common stockholders57,015,159 54,873,675 
Net loss per share attributable to common stockholders — basic and diluted:$(2.19)$(1.84)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following outstanding options, unvested shares, and ESPP shares were excluded (as common stock equivalents) from the computation of diluted net loss per common share for the periods presented as their effect would have been antidilutive (in thousands):
Year Ended December 31,
20232022
Options to purchase common stock5,376,373 7,755,303 
Common stock subject to vesting or repurchase565,667 2,767,526 
Employee Stock Purchase Plan shares— 168,080 
Total5,942,040 10,690,909 
The Company excluded the following potential common shares, presented based on amounts outstanding at period end, from the computation of diluted net loss per share attributable to common stockholders for the period indicated because including them would have had an anti-dilutive effect:
December 31,
20222023
Convertible preferred stock
24,927,83052,947,011
Class A common stock options granted and outstanding
5,271,9619,317,290
Class A common stock warrants
470,000470,000
Preferred stock warrants
814,495814,495
Class B convertible common stock
2,744,1842,744,184
Total
34,228,47066,292,980